Literature DB >> 15699512

Killer cell immunoglobulin-like receptor genes in Latvian patients with type 1 diabetes mellitus and healthy controls.

Liene Nikitina-Zake1, Raja Rajalingham, Ingrida Rumba, Carani B Sanjeevi.   

Abstract

T1DM is very common in Sweden and is positively associated with HLA class II genes. Approximately 89% of the newly diagnosed patients carry the high-risk HLA DR4-DQ8 and DR3-DQ2. The remaining 11% develop T1DM without them. This can be due to involvement of other genes and environmental factors. Natural killer (NK) cells of the innate immune system are important in antiviral and antitumor immunity. They are implicated in the etiology of autoimmune T1DM. Human NK cells express killer cell immunoglobulin-like receptors (KIR) that belong to the polymorphic multigene family in chromosome 19q3.4. They modulate NK cell response by interacting with HLA class I. In addition, polymorphic MICA in HLA class I interacts with non-polymorphic NKG2D receptor on NK cells. We have studied, in addition to HLA-DR and -DQ, genes of the innate immune system MICA and KIR in Latvian patients (n = 98) with T1DM and controls (n = 100). They were genotyped using standard PCR-based typing methods. MICA allele 5 is positively associated with T1DM. KIR2DL2 and KIR2DS2 were both positively associated. Combined association of MICA4 and KIR2DL2 gave an odds ration (OR) of 26.7. However, the combined risk of KIR2DL2 and HLA class II genes, HLADR3 (OR = 73.4), DR4 (OR = 66.8), and DR3 and DR4 (OR = 88.3), was higher. The maximum risk was when KIR2DL2, MICA5, and DR3/DR4 were in combination. In conclusion, our results suggest that a balance between innate and acquired immunity is important, and an imbalance coud lead to T1DM.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15699512     DOI: 10.1196/annals.1337.027

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  15 in total

1.  HLA class I and class II frequencies in patients with cutaneous malignant melanoma from southeastern Spain: the role of HLA-C in disease prognosis.

Authors:  José A Campillo; Jorge A Martínez-Escribano; Manuel Muro; Rosa Moya-Quiles; Luis A Marín; Olga Montes-Ares; Natalia Guerra; Paloma Sánchez-Pedreño; José F Frías; José A Lozano; Ana M García-Alonso; M Rocío Alvarez-López
Journal:  Immunogenetics       Date:  2005-12-20       Impact factor: 2.846

Review 2.  Innate immunity and the pathogenesis of type 1 diabetes.

Authors:  Fabio Arturo Grieco; Francesco Vendrame; Isabella Spagnuolo; Francesco Dotta
Journal:  Semin Immunopathol       Date:  2010-04-10       Impact factor: 9.623

Review 3.  Missing or altered self: human NK cell receptors that recognize HLA-C.

Authors:  Hugo G Hilton; Peter Parham
Journal:  Immunogenetics       Date:  2017-07-10       Impact factor: 2.846

Review 4.  NKG2D ligands as therapeutic targets.

Authors:  Paul Spear; Ming-Ru Wu; Marie-Louise Sentman; Charles L Sentman
Journal:  Cancer Immun       Date:  2013-05-01

5.  Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.

Authors:  Zeying Du; David W Gjertson; Elaine F Reed; Raja Rajalingam
Journal:  Immunogenetics       Date:  2006-11-14       Impact factor: 2.846

6.  Chain-terminating natural mutations affect the function of activating KIR receptors 3DS1 and 2DS3.

Authors:  Lihui Luo; Zeying Du; Surendra K Sharma; Rebecca Cullen; Stephen Spellman; Elaine F Reed; Raja Rajalingam
Journal:  Immunogenetics       Date:  2007-07-24       Impact factor: 2.846

7.  Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses.

Authors:  Golo Ahlenstiel; Maureen P Martin; Xiaojiang Gao; Mary Carrington; Barbara Rehermann
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

Review 8.  Association of KIR gene polymorphisms with Type 1 Diabetes: a meta-analysis.

Authors:  Samaneh Soltani; Shayan Mostafaei; Saeed Aslani; Elham Farhadi; Mahdi Mahmoudi
Journal:  J Diabetes Metab Disord       Date:  2020-07-09

9.  Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.

Authors:  Jonathan Sitrin; Aaron Ring; K Christopher Garcia; Christophe Benoist; Diane Mathis
Journal:  J Exp Med       Date:  2013-05-06       Impact factor: 14.307

10.  RAE1ε ligand expressed on pancreatic islets recruits NKG2D receptor-expressing cytotoxic T cells independent of T cell receptor recognition.

Authors:  Mary A Markiewicz; Erica L Wise; Zachary S Buchwald; Amelia K Pinto; Biljana Zafirova; Bojan Polic; Andrey S Shaw
Journal:  Immunity       Date:  2012-01-12       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.